Abstract
While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons.
| Original language | English |
|---|---|
| Pages (from-to) | 45-51 |
| Number of pages | 7 |
| Journal | Clinical Otolaryngology and Allied Sciences |
| Volume | 14 |
| Issue number | 1 |
| Publication status | Published - 1989 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Otorhinolaryngology
Cite this
Hypaque and steroids in the treatment of sudden sensorineural hearing loss. / Huang, T. S.; Chan, S. T.; Ho, T. L.; Su, J. L.; Lee, F. P.
In: Clinical Otolaryngology and Allied Sciences, Vol. 14, No. 1, 1989, p. 45-51.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Hypaque and steroids in the treatment of sudden sensorineural hearing loss
AU - Huang, T. S.
AU - Chan, S. T.
AU - Ho, T. L.
AU - Su, J. L.
AU - Lee, F. P.
PY - 1989
Y1 - 1989
N2 - While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons.
AB - While the origins of sudden sensorineural hearing loss remain unproven and treatment empirical, the most appropriate therapy remains a matter of controversy. In this paper we have analysed the current forms of treatment, i.e. diatrizoate meglumine, steroids and a vasodilator. The results suggest that although several related factors were shown to indicate a good prognosis regardless of the therapy, none of the currently available regimens produces consistently better results than the spontaneous recovery rate of 65% reported by Mattox & Simmons.
UR - http://www.scopus.com/inward/record.url?scp=0024550630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024550630&partnerID=8YFLogxK
M3 - Article
C2 - 2920456
AN - SCOPUS:0024550630
VL - 14
SP - 45
EP - 51
JO - Clinical Otolaryngology
JF - Clinical Otolaryngology
SN - 1749-4478
IS - 1
ER -